# Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

> **NCT04124081** · PHASE1 · COMPLETED · sponsor: **Beijing Continent Pharmaceutical Co, Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Hydronidone

## Interventions

- **DRUG:** Hydronidone capsules& Entecavir capsules

## Key facts

- **NCT ID:** NCT04124081
- **Lead sponsor:** Beijing Continent Pharmaceutical Co, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-15
- **Primary completion:** 2019-06-15
- **Final completion:** 2019-08-13
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124081, "Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04124081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*